Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
P L Zinzani, F Venturini, V Stefoni, et al.
Blood Cancer Journal
|
May 14, 2016
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results
V Stefoni, B Casadei, C Bottelli, et al.
Case Reports in Hematology
|
July 9, 2019
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
M Malagola, N Polverelli, V Cancelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 29, 2009
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
E Derenzini, M P Fina, V Stefoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2012
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)
P L Zinzani, E Derenzini, C Pellegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
P L Zinzani, M Tani, A Pulsoni, et al.
Scientific Reports
|
May 12, 2023
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer
L Manganaro, S Bianco, P Bironzo, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
P L Zinzani, F Venturini, V Stefoni, et al.
Blood Cancer Journal
|
May 14, 2016
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results
V Stefoni, B Casadei, C Bottelli, et al.
Case Reports in Hematology
|
July 9, 2019
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
M Malagola, N Polverelli, V Cancelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 29, 2009
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
E Derenzini, M P Fina, V Stefoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2012
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)
P L Zinzani, E Derenzini, C Pellegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
P L Zinzani, M Tani, A Pulsoni, et al.
Scientific Reports
|
May 12, 2023
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer
L Manganaro, S Bianco, P Bironzo, et al.
Page
of 8